C139H181F6N35O3 — CID 160636887
bis(1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol);1-[1-(1-bicyclo[1.1.1]pentanyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]-2,2,2-trifluoroethanol;bis(5-[2-(cyclopropylmethyl)-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine (PubChem CID 160636887) has the molecular formula C139H181F6N35O3 and a molecular weight of 2504.21 g/mol. Its IUPAC name is bis(1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol);1-[1-(1-bicyclo[1.1.1]pentanyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]-2,2,2-trifluoroethanol;bis(5-[2-(cyclopropylmethyl)-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine.
| Compound Name | bis(1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol);1-[1-(1-bicyclo[1.1.1]pentanyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]-2,2,2-trifluoroethanol;bis(5-[2-(cyclopropylmethyl)-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine |
|---|---|
| PubChem CID | 160636887 |
| Molecular Formula | C139H181F6N35O3 |
| Molecular Weight | 2504.21 g/mol |
| Exact Mass | 2502.50 |
| IUPAC Name | bis(1-[4-(6-amino-5-methyl-3-pyridinyl)-1-(1-bicyclo[1.1.1]pentanyl)imidazol-2-yl]ethanol);1-[1-(1-bicyclo[1.1.1]pentanyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-2-yl]-2,2,2-trifluoroethanol;bis(5-[2-(cyclopropylmethyl)-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-cyclopropyl-1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[1-[3-(4-methylpiperazin-1-yl)-1-bicyclo[1.1.1]pentanyl]-2-propan-2-ylimidazol-4-yl]pyridin-2-amine |
| SMILES | Cc1cc(-c2cn(C34CC(C3)C4)c(C(C)O)n2)cnc1N.Cc1cc(-c2cn(C34CC(C3)C4)c(C(C)O)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCN(C)CC5)(C3)C4)c(C(C)C)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCN(C)CC5)(C3)C4)c(C3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCN(C)CC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCN(C)CC5)(C3)C4)c(CC3CC3)n2)cnc1N.Cc1ncc(-c2cn(C34CC(C3)C4)c(C(O)C(F)(F)F)n2)cc1C(F)(F)F |
| InChI | InChI=1S/2C23H32N6.C22H30N6.C22H32N6.C17H15F6N3O.2C16H20N4O/c2*1-16-9-18(11-25-21(16)24)19-12-29(20(26-19)10-17-3-4-17)23-13-22(14-23,15-23)28-7-5-27(2)6-8-28;1-15-9-17(10-24-19(15)23)18-11-28(20(25-18)16-3-4-16)22-12-21(13-22,14-22)27-7-5-26(2)6-8-27;1-15(2)20-25-18(17-9-16(3)19(23)24-10-17)11-28(20)22-12-21(13-22,14-22)27-7-5-26(4)6-8-27;1-8-11(16(18,19)20)2-10(6-24-8)12-7-26(15-3-9(4-15)5-15)14(25-12)13(27)17(21,22)23;2*1-9-3-12(7-18-14(9)17)13-8-20(15(19-13)10(2)21)16-4-11(5-16)6-16/h2*9,11-12,17H,3-8,10,13-15H2,1-2H3,(H2,24,25);9-11,16H,3-8,12-14H2,1-2H3,(H2,23,24);9-11,15H,5-8,12-14H2,1-4H3,(H2,23,24);2,6-7,9,13,27H,3-5H2,1H3;2*3,7-8,10-11,21H,4-6H2,1-2H3,(H2,17,18) |
| InChIKey | RIQPXGGJBNLUCC-UHFFFAOYSA-N |
| XLogP | 19.94 |
| TPSA | 457.70 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 183 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2504.21 |
| LogP ≤ 5 | 19.94 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 38 |